fundamental3 | Unsorted

Telegram-канал fundamental3 - Fundamental Analysis (Long term)

47546

https://t.me/+Rn8RmYm0XMZTagXs I'm not a SEBI registered advisor,the information provided by me is for educational purposes only.You are responsible for all investment decisions,plz note that I dont provide any tips/stock suggestion.

Subscribe to a channel

Fundamental Analysis (Long term)

CONCLUSION

EXPECTING 20 TO 25% GROWTH FOR NEXT 2 TO 3 YR KEEP WATCH CLOSLEY

MARGIN REMAIN STABLE AT CURRENT RATE AND IT CAN IMPROVED IN FUTURE

wHILE REVENUE GROWTH GUIDE 15%


DIsclaimer: Above study is not buy sell suggestion , just for learning and educational information which is publicly available , Before buy sell Consult your Financial advisor 🙏🏻

Читать полностью…

Fundamental Analysis (Long term)

Consisting Strong Operating cashflow

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: MARKET LEADERSHIP

Core Leadership
- Sole supplier artificial leather: India auto + marine
- Only Indian direct PU exporter to NA/Europe auto OEMs

PU Market Position
- 1 of 4 PU manufacturers in India
- Domestic share: 5% → 15-20% target

Competitive Edges
- Vertical integration
- In-house R&D + proprietary eco-tech
- Direct top-tier global OEMs
- Agile prototyping/customization

Key Takeaway:
Unique India-global bridge + tech moat = scalable market share gains

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: STRATEGIC MOVES

High-Margin Shift
- De-emphasize low-margin domestic PU
- Target global brands: Zara (fashion), Adidas (footwear), auto OEMs
- Global approval = worldwide scalability

Integration Plans
- JV for PU chemicals: Local production, cut imports
- Warp-knitting plant (Gwalior): Reduce fabric imports
- Atmanirbhar Bharat alignment

Global Expansion
- Mexico land acquisition: New plant on order traction
- US warehousing (₹30 Cr investment); local mfg potential

Retail Push
- Build Texture & Hues brand equity
- Dealer network for furnishing consumer mindshare

Key Takeaway:
Margin upgrade + localization + global footprint = 3-pronged growth engine

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: GLOBAL EXPANSION

Export Markets
- US, UK, South Africa, China, Germany, Mexico, Thailand, Myanmar, Europe

Export Contribution
- 35% total revenue (Aug 2025) ↑ from 27.76% (Aug 2023)

Key Drivers
- European/US auto OEM demand
- Global fashion/sporting goods interest
- China+1 sourcing tailwinds

International Subsidiaries

South Africa
- Mayur Uniquoters SA (Pty) Ltd
- Logistics/trading for Mercedes/BMW EU

USA
- Mayur Uniquoters Corp (Texas): JIT supply
- Futura Textiles Inc (Nevada): Global ops

Europe
- UAB Futura Textiles (Lithuania): EU market access + sustainability

Key Takeaway:
35% export mix + China+1 + subsidiaries = structural revenue diversification

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: CAPACITY BREAKDOWN

Production Capacity (Aug 2025)
- PVC coated fabric: 48.60 Mn linear meters
- PU coated fabric: 5.00 Mn linear meters

Industry Position
- Among largest organized players in India

Manufacturing Footprint

Rajasthan Units
- Jaitpura & Dhodsar: PVC + PU production
- Dhodsar: Captive knitted fabric production

Madhya Pradesh
- Morena (Greenfield PU facility)
- Commissioned Jan 2020
- Expansion ready (up to 4 coating lines)

Utilization
- 70-72% capacity use (Aug 2022)
- Spare capacity for on-time delivery + order ramp-up

Key Takeaway:
Strategic spare capacity + expansion-ready infra supports growth acceleration

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS LTD
CMP: 557

Читать полностью…

Fundamental Analysis (Long term)

TIA 20-20 Ideas Summit TIA_Investors

1. G Maran - Carborundum Universal
2. ⁠Jatin Khemani - Ramco Cements, KCP
3. ⁠Balaji Vaidyanath - Orkla India
4. ⁠Vidya Bala - Shaily Engineering
5. ⁠Chetan Phalke - Arvind Fashions
6. ⁠Kunal Sabnis - Indigo Paints
7. ⁠Abhijit Chokshi - PSP Projects
8. ⁠GR Balaji - Aditya Birla AMC
9. ⁠Sunil Shah - Nippon Life AMC
10. ⁠Naresh Katariya - Vedanta
11. ⁠Gurmeet Chadha - Hind Rectifiers
12. ⁠Koushik Mohan - Azad Engineering
13. ⁠Trilok Agarwal - PayTM
14. ⁠Ganesh Nagarsekar - AIA Engineering
15. ⁠Parthiv Shah - Tenneco Clean Air
16. ⁠Kumar Saurabh - 3B BlackBio Dx
17. ⁠Ishmohit Arora - Aarti Pharmalabs
18. ⁠Sanjay Elangovan - Genesys International
19. ⁠Ankit Kanodia - Fino Payments Bank
20. ⁠Sivaramakrishnan R - Manorama Industries
21. ⁠Josin Sunny - Sundrop Brands

Must visit 👇
@Stockupdate9
@Wealthcreator7

Читать полностью…

Fundamental Analysis (Long term)

India Logistics Showdown – Infrastructure vs Quick Commerce vs Premium Air

I reviewed three listed / scaled players in the same sector — but each is building a very different moat.

Delhivery – The Infrastructure Compounding Play

• Acquired Ecom Express
• Runs one of India’s most integrated freight networks
• Asset-heavy but high entry barriers
• Network density improves operating leverage over time
• Q3 FY26 volume: 295 million parcels

Investor View:
• Betting on scale, automation, and replacement cost moat
• Long-term infrastructure play
• Margin expansion story over time

Shadowfax – The Quick Commerce Leveraged Model

• Deep integration with Blinkit & Zepto ecosystem
• Asset-light, gig-worker heavy structure
• Scales with demand without heavy fixed cost
• Riding the 10-minute delivery behavioral shift
• Q3 FY26 volume: 206 million parcels
• Growth reported at ~65%

Investor View:
• Proxy on Quick Commerce
• High growth, but dependent on consumer trend durability
• More operating volatility

Blue Dart – The Premium Air Cargo Specialist

• Owns 8 aircraft
• Strong brand in time-critical deliveries
• Dominant in high-value B2B shipments
• Q3 FY26 volume: 107 million parcels

Structural Risk:
• GST removed interstate checkpoints
• Highway infrastructure improving
• Surface transport cost gap narrowing

Investor View:
• Premium moat, brand trust
• Needs adaptation as road logistics improves
• Cash-flow stable but growth may moderate

Big Picture

• Total market expanding fast
• All three growing simultaneously
• No clear loser yet

Key Question Ahead

When growth normalizes, who has:
• Lowest cost per parcel?
• Highest network efficiency?
• Strongest pricing power?

My Structured Take

• Delhivery → Infrastructure winner over long term
• Shadowfax → High growth next 3–5 years
• Blue Dart → Defensive, but must evolve


The real battle begins when growth slows and operating efficiency decides survival.

Читать полностью…

Fundamental Analysis (Long term)

STERLITE TECHNOLOGIES (STL) – FROM TELECOM CYCLE TO AI INFRASTRUCTURE STORY

Investment Thesis – The Physical Backbone of AI

AI scaling needs fiber.
Not just software.

AI growth requires:
• Ultra-dense data centers
• Inter-DC connectivity
• 5G densification
• FTTx expansion

GPU racks need up to 36x more fiber vs CPU racks.
DC fiber density is ~70% higher.

STL is shifting from telecom vendor to compute-infrastructure enabler.

AI & Data Center – Core Structural Driver

Enterprise & Data Center mix:
• Current contribution: ~20% of YTD FY26 revenue
• Target: 30% mix in 12–18 months
• Recent wins: ~₹500 crore orders

Premium AI/DC portfolio:
• 160-micron ultra-slim fiber
• 864-fiber ribbon cable
• IBR cables up to 3,456 fibers
• High-density DC micro-cables
• OptoFit connectivity systems

Higher mix supports 20% EBITDA margin ambition.

Strategic Positioning – Glass to Gigabit Integration

STL is vertically integrated across the optical chain.

Control across:
• Silicon processing
• Glass preforms
• Fiber drawing
• Cable manufacturing
• Network deployment

Competitive edge:
• Cost leadership
• Quality control
• Faster innovation

IP strength: 780+ patents
Global OFC share: ~8% (ex-China)
Ambition: Top-3 global optical player.

Technology Leadership – Future Ready Fiber

G.654.E fiber:
~30% lower signal loss
• Built for 400G/800G networks
• Higher realizations

Hollow-Core fiber:
30–47% lower latency
• Early commercialization stage

Multicore fiber:
4–7x capacity in same footprint
• 100-km live trials completed
• Quantum-ready deployments initiated

Technology depth improves pricing power.

Financial Performance – Improving Fundamentals

Q3 FY26 revenue: ₹1,257 crore
YTD FY26 revenue: ₹3,311 crore (↑ 12% YoY)

YTD order intake: ₹4,263 crore (↑ 40.3% YoY)
Open order book: ₹5,325 crore

Margin profile:
• Reported Q3 EBITDA margin: 10.3%
• Operational EBITDA margin: 17.9%
• Fifth consecutive quarter of improvement

YTD EBITDA: ₹410 crore (↑ 35% YoY)

Tariff impact created temporary headwind.
Proposed reduction improves margin visibility.
Path toward 20% EBITDA margin at optimal utilization.

Capital Structure – Controlled Leverage

• Net debt: ₹1,331 crore
• Debt-to-equity: 0.87
• Net debt-to-EBITDA: 2.58x

Balance sheet remains manageable.
Capex focused on U.S. facility and R&D.

Key Risks

• Germanium supply concentration risk
• Slow adoption of hollow-core and multicore
• U.S. tariff policy changes
• Legal and regulatory overhang

Key Metrics to Monitor

• Enterprise/DC mix toward 30%
• EBITDA margin trajectory toward 20%
• Order inflow growth
• Capacity utilization
• U.S. plant ramp-up

Conclusion – Structural Transition Underway

STL is moving from cyclical telecom exposure to structural AI infrastructure play.
Execution and margin expansion will drive re-rating.
Data center mix and profitability trend remain the key triggers.

Читать полностью…

Fundamental Analysis (Long term)

Sakar Healthcare – Business Model & Re-rating Triggers

Most investors track Sakar for oncology growth.
But the real story is the business model transition.

Let’s break it down clearly

Sakar Healthcare – Business Model Explained

Sakar operates as an integrated oncology-focused pharma player with three key engines:

1️⃣ Oncology Formulations (FDF) – Core Growth Driver
▪️ EU GMP approved oncology facility (Bavla)
▪️ Manufactures oral solids, liquids, injectables
▪️ Supplies to partners across EU & emerging markets
▪️ Increasing share of high-margin exports

This is where scalable earnings are built.

2️⃣ Tech Transfer Model – Revenue Visibility Layer
- Sakar manufactures under partner marketing authorisations (e.g., Accord/Intas & others).
- Structure typically includes:
▪️ Forecast + minimum commitments
▪️ Trial shipment first
▪️ Batch-scale repeat orders
▪️ Potential bi-monthly ordering rhythm

Why this matters:
This converts a volatile pharma export model into a semi-contractual revenue stream.

3️⃣ Backward Integration (API + CEP) – Margin Lever
▪️ 21 APIs developed
▪️ CEP filings underway
▪️ Integration into EU supplies improves cost control

- This is the future margin flywheel.
Without integration → 25–26% margin
With integration → pathway to ~30% margin

Where Earnings Come From
Revenue mix evolution:

Old Model:
▪️ Generic exports
▪️ Domestic business
▪️ Variable margins

New Model (Emerging):
▪️ Oncology-dominant
▪️ EU commercialization
▪️ Tech transfer stability
▪️ Backward integration

This is a quality upgrade story, not just a growth story.

Re-rating Triggers
Th
e market will not re-rate Sakar on:

▪️ Dossier count
▪️ Approval announcements
▪️ Guidance statements

It will re-rate on execution proof.

Here are the real triggers

1️⃣ EU Revenue Becomes Meaningful
Not approvals - actual revenue contribution.

Trigger:
▪️ EU contributing consistently in quarterly numbers
▪️ Repeat dispatch cycles visible

2️⃣ Tech Transfer Repeatability
Pip
eline → Revenue → Repeat Orders.

Trigger:
▪️ Bi-monthly rhythm
▪️ Stable volumes
▪️ Reduced quarterly volatility

This shifts perception from exporter → platform supplier.

3️⃣ Margin Durability Near 30%
Curr
ent EBITDA ~26%.
Management target ~30%.

Trigger:
▪️ Two to three quarters sustaining 28–30%
▪️ Gross margin stability
▪️ No working capital stress

Margin stability = multiple expansion.

4️⃣ Capex Ends → Operating Leverage Visible
▪️ M
ajor capex completed
▪️ No major FY27 capex

Trigger:
▪️ EBITDA grows faster than revenue
▪️ PAT converts to cash

When earnings convert to FCF, valuation changes.

5️⃣ Cash Flow Tracking PAT
This is
critical.

Trigger:
▪️ CFO ≈ PAT
▪️ Working capital stable
▪️ No sudden receivable stretch

Cash visibility removes execution discount.

Читать полностью…

Fundamental Analysis (Long term)

Clean Science- Products and Business Summarised

Traditional Antioxidant Business Under Pressure

• The traditional antioxidant segment is facing multiple headwinds.
• Chinese competition has intensified.
• High U.S. tariffs have added pressure.
• This has created a double impact on Clean Science.

• In 4-Methoxyphenol (MEHQ), Vinati Organics has emerged as a local competitor.
• Pricing pressure has increased.

• In Butylated Hydroxyanisole (BHA), U.S. import tariffs are around 55%.
• The U.S. is the primary export market.
• Exports have nearly stopped due to high tariffs.

• Customer sentiment remains cautious.
• Price volatility continues.
• Geopolitical risks remain high.
• Demand visibility is limited.
• Customers are buying on a hand-to-mouth basis.
• Asian downstream demand has softened significantly.

• AJC expects these headwinds to continue for 4–6 months.
• Volume sales may remain under pressure.
• Margins may stay impacted.

Hindered Amines Light Stabilizers (HALS) – High Entry Barrier Additive Space

Global Leaders

• BASF (Tinuvin), Clariant (Hostavin), Sabo (Italy), ADEKA (Japan), Songwon (Korea), Rianlon (China).
• BASF and Clariant dominate the global market.
• They operate fully integrated plants in EU, USA, and China.
• The market is controlled by a few integrated players.
• These players have strong IP moats.
• Global HALS market size is ~$1.2–1.5 billion.
• It is niche and customer-sticky.

Entry Barriers

• Multi-step and amine-heavy chemistry.
• Tight purity and color specifications.
• Strong patent protection on grades 770, 622, 292, and 123.
• High EHS compliance costs.
• Toxic intermediates increase complexity.
• Long customer qualification cycles.

Business Prospects

• India will remain the primary revenue driver.
• Products are not globally competitive on pricing.
• Product portfolio is relatively narrow.
• Export potential is limited in the near term.

• Domestically, the company has around 50% market share in key segments.
• It has filed an anti-dumping duty (ADD) petition on HALS 770.
• Imports are from the EU and China.
• This highlights a price gap with overseas producers.
• Clean Science’s costs are higher than European and Chinese peers.
• The strategy aims to protect domestic margins.
• It also aims to safeguard market share.

Disclaimer

• This overview by Ajay Joshi Chemicals is for educational purposes only.
• It is not investment advice.
• It is not a recommendation to buy, sell, or hold securities.
• Consult a SEBI registered financial advisor before making investment decisions.

More at ⤵️
@Stockupdate9

Читать полностью…

Fundamental Analysis (Long term)

ABB Says

Of The ₹10,000 Cr Order Backlog, 30% Is Large Orders Where Execution Is Beyond A Year

See Growth Across Sectors: Automotive, Renewables, Data Centers & Core Sectors As Well

15% Of The Orderbook Is Data Center Dedicated

Читать полностью…

Fundamental Analysis (Long term)

POCL Enterprises Q3FY26: PAT +52% | 10-15x PE

Financial Surge
- Q3 revenue ₹364 Cr (+6.8% YoY).
- Q3 PAT ₹8.51 Cr (+51.6% YoY).
- 9M PAT ₹29.91 Cr (+39% YoY).
- Metallic Oxides +30% YoY drives growth.

Business Verticals
- Metals (Pb/Zn smelting), Metallic Oxides (battery/paint), Plastic Additives (PVC stabilizers).

Capacity Expansion
- 11k MTPA Pb smelting at Maraimalai Nagar (2025).
- 2.4k MTPA Lead-Free Stabilizer scaling.

Strategic Shifts
- ESG: Furnace oil → LPG at Puducherry.
- 40% stake in PlanetFirst Green (Jun25) for lead recycling.

Fundamentals
- ROE ~37%, ROCE ~32%; EBITDA ~4.5%.
- Exports ~67%; WC needs watch.

Key Takeaway
Oxides-led growth + green shift unlocks margin re-rating potential.

More at ⤵️
@Stockupdate9

Читать полностью…

Fundamental Analysis (Long term)

Time Technoplast Q3FY26: Explicit Growth Outlook

Segment Growth
- Packaging (75% biz): 11-13% (overseas >13%; India 10-11%).
- Composites/auto: 25-30% (capacity/products by Q4 FY26).
- PE Pipes: >20% (current capex FY26/27; Odisha FY27/28+).

Margin Levers
- Value-added mix shift, automation/robotics.
- Plant consolidation, solar/open-access power.
- Lower finance costs, WC compression.

PAT Thesis
- PAT to exceed volume growth via deleveraging savings.

Key Takeaway
15-20% revenue + margin levers drive PAT acceleration beyond volumes.

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS Q3 FY26: DETAILED SUMMARY

Financial Performance
Standalone
- Revenue: ₹236.99 Cr (+22% YoY)
- PBT: ₹70.08 Cr (+71% YoY)
- PAT: ₹52.93 Cr (+77% YoY)

Consolidated
- Revenue: ₹237.48 Cr (+14% YoY)
- PBT: ₹67.16 Cr (+58% YoY)
- PAT: ₹50.73 Cr (+66% YoY)

Profit Drivers
- Export mix improvement
- Operating efficiencies
- FX gains (~50% other income, no reversal risk)

Revenue Breakdown
Exports (₹97 Cr | 41%)
- Export OEM: ₹26.45 Cr
- Export General: ₹20.73 Cr

Domestic (₹140 Cr | 59%)
- Auto OEM: ₹52.01 Cr
- Replacement: ₹38.84 Cr
- Footwear: ₹39.93 Cr
- Furnishing: ₹6.47 Cr

Volumes
- Total: 76.3 lakh meters
- PU: 2.56 lakh meters (value ₹6.17 Cr)

Strategic Updates

Export Momentum
- "Momentum continues 2-3 years"
- Preferred supplier for US/EU OEMs

Domestic Discipline
- Target 8-10% growth
- Avoid low-margin volumes
- Footwear hit by local price competition

Capex Pathways (Mutually Exclusive)
Option 1: South India PVC
- Capex: ₹200 Cr
- Capacity: 500k → 1 Mn mm/month
- Timeline: 2 years

Option 2: Overseas Plant
- Capex: ₹300 Cr
- Tariff/deglobalization hedge
- Mexico/US/EU evaluation

Other Highlights
- Europe setup: New Estonia company for non-auto
- EU duty relief: 10-12 months expected
- Raw materials: 33-65% imports (TBC)
- Pricing: USD-fixed exports; pass-through on major input hikes
- PU: China imports pressure; waiting firm orders

Guidance
- 15% revenue growth (value basis)
- Margin sustainability: 24-25% EBITDA
- No near-term tariff impact

Key Takeaway
Export-led profitability surge + disciplined domestic + capex optionality positions for sustained 15%+ growth with margin stability

More Concall at ⤵️
@Concalls3

Читать полностью…

Fundamental Analysis (Long term)

margin expanded 18% to 23%

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: FINANCIAL HIGHLIGHTS

Auto Exports Outlook
- Projected growth: ₹1.1 lakh Cr → ₹3 lakh Cr (next 2 years, Nov 2022 view)

PU Business
- Currently loss-making (Aug 2024)
- High potential via premium product mix

Q1 FY26 Performance (Aug 2025)
- Auto OEM sales ↑ vs Q1 FY25
- Sales volume: 71.31 lakh meters ↑ from 70.41 lakh

Dealer Network
- ~1,000 dealers for auto replacement market

US Exports
- Maintains stock for demand
- Unaffected by 25% tariffs

Export Volumes
- South Africa: 30-35k meters/Q to BMW & Mercedes each
- Target: 300k yards/month by FY25 (↑ from 115k)

Key Takeaway:
Volume growth + export ramp-up offsets PU losses for steady profitability

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: SUSTAINABILITY & INNOVATION

R&D Strategy
- Core focus: texture, color, performance, sustainability
- 90-100 unique samples daily

New R&D Center
- Planned 2025: World-class eco-friendly facility
- Customer-centric + tech-advanced synthetics

Sustainable Products
- 100% Vegan PU Leather: Animal-free, non-toxic
- Eco-Friendly PU: No water solvents, DMF, lead, toluene
- REACH compliant; resists tropical/hydrolysis/aging

Proprietary Tech
- One of 3 global manufacturers (only Indian)
- DMF/solvent-free high-solid PU = competitive moat

Key Takeaway:
R&D leadership + green tech positions Mayur for premium global OEM wins

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: BUSINESS SEGMENTS

Automotive OEMs
- Global: Mercedes-Benz, BMW, Chrysler, Ford, Volkswagen, Stellantis, Hyundai, Toyota
- India: Maruti Suzuki, Tata Motors, Mahindra, MG, Kia
- Key wins: Sole supplier Stellantis USA; BMW Thailand/South Africa/US; Chrysler premium PU

Footwear
- Domestic: Bata, Relaxo, VKC Group
- International: Aditya Birla, Adidas
- PU materials for uppers/insoles/linings

Furnishing & Retail
- "Texture & Hues" brand via Mayur Tecfab subsidiary
- 750+ dealers; 20k meters/month sales
- Vegan leather for sofas, cinemas, décor

Leather Goods & Garments
- Expanding PU for bags, belts, apparel
- Sustainable alternatives focus

Key Takeaway:
Auto + exports leadership positions for structural margin expansion

Читать полностью…

Fundamental Analysis (Long term)

MAYUR UNIQUOTERS: SYNTHETIC LEATHER LEADER

Core Business
- India's top synthetic leather manufacturer
- Specializes in PVC & PU coated fabrics

Industry Experience
- 25+ years in artificial leather
- Strong B2B model

Key End Markets
- Global automotive OEMs
- Footwear brands
- Furnishing manufacturers

Competitive Strengths
- Robust R&D capabilities
- Vertical integration
- Expanding international footprint

Strategic Positioning
- Global leader in sustainable, high-performance synthetics

Key Takeaway:
Auto + exports exposure positions Mayur for structural growth in green materials

Читать полностью…

Fundamental Analysis (Long term)

One Interesting Company Study will shared

Читать полностью…

Fundamental Analysis (Long term)

Logistics Stocks: Margins Set to Explode Once Scale Kicks In

Fixed-cost business model
- Logistics players bear heavy fixed costs — warehouses, trucks, tech platforms.
- Once volumes scale up and fixed costs are covered, incremental revenue flows almost entirely to profit.
- Current P/E ratios appear high because margins are still low (3–4%), but investors are pricing in sharp margin expansion ahead.

Delhivery: Core engine gaining traction
- Core Express business already operating at ~16–18% margins.
- As truck utilization rises, Return on Invested Capital (ROIC) is projected to reach 25–30%.
- Higher utilization = margin expansion = steep drop in effective P/E ratio.
- Market sentiment reflects belief in this future profitability curve.

Shadowfax: Building for profitable scale
- Currently in heavy investment mode – opening 80–100 facilities per month, depressing short-term profit.
- EBITDA margin surged from 0.5% → 4.3% within a year.
- Once expansion phase slows, profits expected to accelerate sharply due to its asset-light operating model.

Key Takeaway:
High P/E today doesn’t mean overvaluation — it signals market confidence in explosive margin expansion once operational leverage kicks in.

Читать полностью…

Fundamental Analysis (Long term)

When you build in silence, people don't know what to attack.

Читать полностью…

Fundamental Analysis (Long term)

Sterlite Technologies — Building the Highways of the AI Economy (Before the Traffic Arrives)

Читать полностью…

Fundamental Analysis (Long term)

ABB INDIA SAYS

Strong cash collections; inventory aligned for future deliveries

Resilient domestic market despite geopolitical and trade uncertainties

Chemicals, textiles, F&B, and automobiles seen as top beneficiaries

Well positioned to serve 23 diverse market segments

Positive order momentum from the renewables segment

Encouraging growth for smart building solutions

Positive momentum for propulsion systems for railways

India-Europe FTA has the potential to enhance margin resilience

Читать полностью…

Fundamental Analysis (Long term)

BIOCON MGMT Says

New Biosimilar Launches To Reflect In FY27

Next 12 Months Are Far More Exciting

Q3 Margin Good In The Biocon Biologics Biz

Diabetes Drugs Are Chronic Therapies, Have To Be For A Long Period

Limited Competition In Insulins

Читать полностью…

Fundamental Analysis (Long term)

HEXAWARE TECH Says

Coded Wisdom Sitting Inside Code Will Be Employed In Enterprise

Businesses Wanting To Scale To Have Use Case For Collaboration

Roadmap Is To Cater To Existing Brownfield Enterprises

Eyeing To Convert Stories Into High Fidelity & Employ Resources

GenAI Having Most Profound Impact On Software Engineering

Innovation Will Be Moving Towards More Core Engineering

Читать полностью…

Fundamental Analysis (Long term)

Time Technoplast Q3FY26: Key Watch Items & Risks

Execution Risks
- Solar savings state-dependent (policy constraints).
- Hydrogen/drone supply gated until Apr 2026 expansion.

Deal Uncertainty
- Flexible IBC (Ebullient) pending due diligence/Board; Mar 2026 target (may extend).

Commodity Impact
- Lower polymer prices cap revenue vs volumes (margin/WC positive).

Key Takeaway
Policy/deal delays pose near-term risks, but core levers intact for 20% ROCE path.

Читать полностью…

Fundamental Analysis (Long term)

Time Technoplast Q3FY26: Packaging & Pipes Capacity Ramp

IBC Automation
- Silvassa Phase 1: Fully automated, ~1.5 lakh units/year.
- Phase 2 targeted FY26/27.

PE Pipes
- Gummidipoondi (near Chennai): +40,000 sq ft; operational.

New Footprint
- Gujarat: ~3-acre plot allotted (agreement process) for FY26/27.
- Odisha: Govt leasehold land; building/equipment underway for infra PE pipes.
- Maharashtra (TPL Plastech 75% sub): >5-acre Chiplun land near chemical cluster; ₹30-35 Cr capex for IBC packaging, >₹100 Cr revenue in 3 years (FY26/27 complete).

Key Takeaway
Multi-site expansions target IBC/pipes scale-up to >₹100 Cr incremental revenue.

Читать полностью…
Subscribe to a channel